Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1035620140020050394
Allergy Asthma & Respiratory Disease
2014 Volume.2 No. 5 p.394 ~ p.397
Successful desensitization for cytarabine induced anaphylaxis
ÀÌÇö¿ì:Lee Hyun-Woo
¹ÚÀç¿ë:Park Jae-Yong/¹®ÁØÈ£:Moon Joon-Ho/¹Ú°æÅÃ:Park Kyung-Taek/¹ÚÇѱâ:Park Han-Ki/°­Çý·Ã:Kang Hye-Ryun
Abstract
Cytarabine is a very important chemotherapeutic agent for leukemia and lymphoma patients and is prescribed more frequently than before. Cytarabine-induced delayed-onset hypersensitivity may rarely present as non-IgE mediated anaphylaxis. However, we do not know yet whether desensitization therapy in adults may be effective in cytarabine-induced delayed-onset anaphylaxis. A 78-year-old woman who was diagnosed with acute myeloblastic leukemia had chemotherapy including cytarabine. In spite of premedication with hydrocortisone and chlorpheniramine, the patient had anaphylaxis a few hours after cytarabine infusion. We decided to perform desensitization therapy. After desensitization therapy using a newly designed protocol, the patient was tolerable to cytarabine infusion without hypotension or high fever. Desensitization therapy was successfully performed on an adult patient with delayed-onset anaphylaxis caused by cytarabine.
KEYWORD
Anaphylaxis, Cytarabine, Immunologic desensitization
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed